Morgan Stanley Maintains Overweight on HF Sinclair, Raises Price Target to $70
Morgan Stanley analyst Connor Lynagh maintains HF Sinclair (NYSE:DINO) with a Overweight and raises the price target from $65 to $70.
Uncategorized
From BZ Small Cap Event: Virios Therapeutics CEO Greg Duncan Now Speaking Live
https://www.youtube.com/watch?v=Jrcq_ymSBt0
Related Posts
WHP Global Acquires Controlling Stake In Isaac Mizrahi Fashion Brand From Xcel Brands For $68M
Xcel Brands, Inc. (NASDAQ:XELB) ("Xcel" or the "Company"), a media and consumer products company with significant expertise in livestream shopping on TV and online, and WHP
Vuzix Receives, Delivers Significant Follow-On Smart Glasses Order To Fortune 50 Global Retailer To Support Warehousing And Logistics Operations; Order Valued At Over $400K
- Vuzix® Corporation (NASDAQ:VUZI), ("Vuzix" or, the "Company"), a leading supplier of Smart Glasses and Augmented Reality (AR) technology and products, today announced that the Company
Wedbush Maintains Outperform on Comerica, Lowers Price Target to $84
Wedbush analyst David Chiaverini maintains Comerica (NYSE:CMA) with a Outperform and lowers the price target from $95 to $84.